Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vestipitant oral and intravenous formulations plus ondansetron for prevention of postoperative nausea and vomiting in high-risk women
2004-001021-22Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vestipitant in postoperative nausea and vomiting (PONV), sponsored by GSK. Started Nov 2004; status: completed.
02
Drugs
vestipitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on 2004-001021-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001021-22.